AXA EQUITABLE HLDGS Price on November 18, 2024
| 054561AM7 | 86.86 6.00 6.46% |
If you're considering investing in 054561AM7 Bond, it is important to understand the factors that can impact its price. As of today, the current price of 054561AM7 stands at 86.86, as last reported on the 29th of November, with the highest price reaching 86.86 and the lowest price hitting 86.86 during the day. AXA EQUITABLE HLDGS retains Efficiency (Sharpe Ratio) of -0.0873, which signifies that the bond had a -0.0873% return per unit of price deviation over the last 3 months. 054561AM7 exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm 054561AM7's Market Risk Adjusted Performance of 0.3484, variance of 2.12, and Information Ratio of (0.17) to double-check the risk estimate we provide.
054561AM7 Bond price history is provided at the adjusted basis, taking into account all of the recent filings.
054561AM7 |
Sharpe Ratio = -0.0873
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 054561AM7 |
Estimated Market Risk
| 1.39 actual daily | 12 88% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average 054561AM7 is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of 054561AM7 by adding 054561AM7 to a well-diversified portfolio.
Related Headline
Esperion Therapeutics Headline on 18th of November 2024
Esperion Highlights New Exploratory Data from CLEAR Outcomes... by finance.yahoo.com
An Exploratory Analysis Reports Patients with PAD Who Took Bempedoic Acid Were 36 percent Less Likely to Experience a Major Adverse Limb Event Compared to Placebo ANN ARBOR, Mich., Nov. 18, 2024 -- Esperion today announced the presentation of an analysis from the CLEAR Outcomes study focused on patients with Peripheral Artery Disease who were unable or unwilling to take statin medications. These data were presented today in an oral featured science presentation
054561AM7 Valuation on November 18, 2024
It is possible to determine the worth of 054561AM7 on a given historical date. On November 18, 2024 054561AM7 was worth 90.6 at the beginning of the trading date compared to the closed value of 90.6. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of 054561AM7 bond. Still, in general, we apply an absolute valuation method to find 054561AM7's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of 054561AM7 where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against 054561AM7's related companies.
| Open | High | Low | Close | Volume | |
| 89.91 | 89.91 | 89.91 | 89.91 | 1.00 | |
11/18/2024 | 90.60 | 90.60 | 90.60 | 90.60 | 1.00 |
| 91.39 | 91.39 | 91.39 | 91.39 | 1.00 |
| Backtest 054561AM7 | | | 054561AM7 History | | | 054561AM7 Valuation | Previous | Next |
054561AM7 Trading Date Momentum on November 18, 2024
| On November 19 2024 AXA EQUITABLE HLDGS was traded for 91.39 at the closing time. The highest price during the trading period was 91.39 and the lowest recorded bid was listed for 91.39 . There was no trading activity during the period 1.0. Lack of trading volume on November 19, 2024 contributed to the next trading day price jump. The trading price change to the next closing price was 0.87% . The overall trading delta to the current price is 4.13% . |
About 054561AM7 Bond history
054561AM7 investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for 054561AM7 is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in AXA EQUITABLE HLDGS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing 054561AM7 stock prices may prove useful in developing a viable investing in 054561AM7
054561AM7 Bond Technical Analysis
054561AM7 technical bond analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, bond market cycles, or different charting patterns.
Price Boundaries
054561AM7 Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
AXA EQUITABLE HLDGS cannot be verified against its exchange. Please verify the symbol is currently traded on Bond Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
054561AM7 November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how 054561AM7 bond reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading 054561AM7 shares will generate the highest return on investment. By undertsting and applying 054561AM7 bond market strength indicators, traders can identify AXA EQUITABLE HLDGS entry and exit signals to maximize returns
054561AM7 Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for 054561AM7's price direction in advance. Along with the technical and fundamental analysis of 054561AM7 Bond historical price patterns, it is also worthwhile for investors to track various predictive indicators of 054561AM7 to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.34) | |||
| Treynor Ratio | 0.3384 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in 054561AM7 Bond
054561AM7 financial ratios help investors to determine whether 054561AM7 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 054561AM7 with respect to the benefits of owning 054561AM7 security.